| 1 |
33073679 | mTOR Inhibition Ablates Cisplatin-Resistant Salivary Gland Cancer Stem Cells. | 2021 Apr |
3 |
| 2 |
32594094 | Down-Regulation of the Mammalian Target of Rapamycin (mTOR) Pathway Mediates the Effects of the Paeonol-Platinum(II) Complex in Human Thyroid Carcinoma Cells and Mouse SW1736 Tumor Xenografts. | 2020 Jun 28 |
2 |
| 3 |
30109500 | MiRNAs and their interplay with PI3K/AKT/mTOR pathway in ovarian cancer cells: a potential role in platinum resistance. | 2018 Dec |
1 |
| 4 |
30237852 | mTORC1/2 inhibition re-sensitizes platinum-resistant ovarian cancer by disrupting selective translation of DNA damage and survival mRNAs. | 2018 Sep 4 |
1 |
| 5 |
26964739 | Dynamic modulation of phosphoprotein expression in ovarian cancer xenograft models. | 2016 Mar 10 |
1 |
| 6 |
27196780 | Dual mTORC1/2 Inhibition as a Novel Strategy for the Resensitization and Treatment of Platinum-Resistant Ovarian Cancer. | 2016 Jul |
1 |
| 7 |
27677586 | Differential network analysis from cross-platform gene expression data. | 2016 Sep 28 |
1 |
| 8 |
26039708 | Somatic Copy Number Abnormalities and Mutations in PI3K/AKT/mTOR Pathway Have Prognostic Significance for Overall Survival in Platinum Treated Locally Advanced or Metastatic Urothelial Tumors. | 2015 |
1 |
| 9 |
26675567 | Potential targets for ovarian clear cell carcinoma: a review of updates and future perspectives. | 2015 |
1 |
| 10 |
25026285 | CD157 enhances malignant pleural mesothelioma aggressiveness and predicts poor clinical outcome. | 2014 Aug 15 |
1 |
| 11 |
23408298 | A phase 1 study of everolimus plus docetaxel plus cisplatin as induction chemotherapy for patients with locally and/or regionally advanced head and neck cancer. | 2013 May 15 |
3 |
| 12 |
22322152 | E Platinum, a newly synthesized platinum compound, induces autophagy via inhibiting phosphorylation of mTOR in gastric carcinoma BGC-823 cells. | 2012 Apr 5 |
3 |
| 13 |
22901187 | Genetic variants in the PI3K/PTEN/AKT/mTOR pathway predict platinum-based chemotherapy response of advanced non-small cell lung cancers in a Chinese population. | 2012 |
2 |
| 14 |
20447721 | PI3K/PTEN/AKT/mTOR pathway genetic variation predicts toxicity and distant progression in lung cancer patients receiving platinum-based chemotherapy. | 2011 Jan |
1 |